| 产品名称： | Bacillus megaterium de Bary |
|---|---|
| 商品货号： | TS184756 |
| Strain Designations： | 310m-151-B8 |
| Application： | Produces inosine Produces inosinic acid 5-inosinic acid, IMP, inosine monophosphate |
| Isolation： | UV-induced, adenine and guanine or xanthine-requiring mutant |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 3: Nutrient agar or nutrient broth |
| Growth Conditions： | Temperature: 30°C
Atmosphere: Aerobic |
| Name of Depositor： | Takeda Chem. Ind., Ltd. |
| U.S. Patent Number： | |
| References： | Yoneda M, et al. Method for the production of 5-inosinic acid and inosine. US Patent 3,409,507 dated Nov 5 1968 |
| Cross References： | Nucleotide (GenBank) : M32342 M.gallisepticum Trp-tRNA-UGA gene. Nucleotide (GenBank) : M32343 M.gallisepticum Pro-tRNA-CCA gene. Nucleotide (GenBank) : X16462 Mycoplasma gallisepticum tuf gene for elongation factor tu. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Bacillus megaterium de Bary |
|---|---|
| 商品货号： | TS184756 |
| Strain Designations： | 310m-151-B8 |
| Application： | Produces inosine Produces inosinic acid 5-inosinic acid, IMP, inosine monophosphate |
| Isolation： | UV-induced, adenine and guanine or xanthine-requiring mutant |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 3: Nutrient agar or nutrient broth |
| Growth Conditions： | Temperature: 30°C
Atmosphere: Aerobic |
| Name of Depositor： | Takeda Chem. Ind., Ltd. |
| U.S. Patent Number： | |
| References： | Yoneda M, et al. Method for the production of 5-inosinic acid and inosine. US Patent 3,409,507 dated Nov 5 1968 |
| Cross References： | Nucleotide (GenBank) : M32342 M.gallisepticum Trp-tRNA-UGA gene. Nucleotide (GenBank) : M32343 M.gallisepticum Pro-tRNA-CCA gene. Nucleotide (GenBank) : X16462 Mycoplasma gallisepticum tuf gene for elongation factor tu. |
